Skip to content

ACRYSOF® SN6AT5 (REF SN6AT5.240)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof(R) IQ TORIC ASTIGMATISM IOL, SINGLE-PIECE ACRYLIC FOLDABLE LENS, UV WITH BLUE LIGHTFILTER, 13.0mm LENGTH, 6.0mm BICONVEX TORICASPHERIC OPTIC, 3.00 D CYLINDER. · Class 3 · Implant

All models of ACRYSOF (353)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652251075), received between Oct 26, 2021 and Mar 3, 2023 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Device Dislodged or Dislocated1
  • Scratched Material1

Patient problems

  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 3, 2023Scratched Material; Scratched Material

    A NON-HEALTH CARE PROFESSIONAL REPORTED DURING THE INTRAOCULAR LENS IMPLANTATION THE SURGEON OPENED THE LENS AND INSERTED IT INTO THE CARTRIDGE AND INJECTED IT INTO THE PATIENT'S EYE. IT WAS NOTICED THAT THE OPTICS WERE SCRATCHED AND THE LENS HAD TO BE REMOVED AND REPLACED WITH A SIMILAR LENS. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 16476316 ↗
  • InjuryOct 26, 2021Device Dislodged or Dislocated; Device Dislodged or Dislocated

    AN ACCOUNT MANAGER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE IOL WAS DISLOCATED IN THE EYE. THE IOL WAS EXCHANGED IN A SECONDARY PROCEDURE 21 DAYS FOLLOWING THE INITIAL PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12698022 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page